KENALOG Side Effects

6303569-5 | Injection Site Reaction, Injection Site Scar, Scar Pain
on Aug 07, 2009 Female patient from UNITED STATES , 18 years of age, weighting 115.0 lb, was treated with Kenalog (View Usage). Patient experienced the following unwanted or unexpected effects: injection site reaction, injection site scar, scar pain. Kenalog dosage: .

6298053-1 | Skin Atrophy, Skin Disorder
Patient was taking Kenalog (View Usage). Patient had the following side effects: skin atrophy, skin disorder on Aug 04, 2009 from UNITED STATES Additional patient health information: Female patient , weighting 130.0 lb, was diagnosed with sinusitis (What is sinusitis?), upper respiratory tract infection and. Kenalog dosage: Once, Im. During the same period patient was treated with . (View . Review and . Label ).

6297771-9 | Injection Site Discolouration, Injection Site Induration, Menopause, Oligomenorrhoea, Therapeutic Response Decreased
Adverse event was reported on Aug 04, 2009 by a Female patient taking Kenalog (View Usage) (Dosage: Kenelog 80 - 1 Shot One Time) was diagnosed with rheumatoid arthritis (What is rheumatoid arthritis?) and. Location: UNITED STATES , 49 years of age, weighting 130.0 lb, After Kenalog was administered, patient had the following side effects: injection site discolouration, injection site induration, menopause (What is menopause?), oligomenorrhoea, therapeutic response decreased.

6290801-X | Depression, Injection Site Discolouration, Injection Site Reaction, Mood Swings
on Jul 29, 2009 Female patient from UNITED STATES , 26 years of age, weighting 110.0 lb, was diagnosed with arthropod bite and was treated with Kenalog (View Usage). Patient experienced the following unwanted or unexpected effects: depression (What is depression?), injection site discolouration, injection site reaction, mood swings. Kenalog dosage: 40mg 1 Im.


6267845-7 | Depression, Injection Site Atrophy, Injection Site Pain
on Jul 09, 2009 Female patient from UNITED STATES , 29 years of age, weighting 115.0 lb, was diagnosed with rash (What is rash?), upper respiratory tract infection and was treated with Kenalog (View Usage). Patient had the following side effects: depression (What is depression?), injection site atrophy, injection site pain. Kenalog dosage: 1ml - 40mg Im.

6249608-1 | Atrophy, Eyelid Disorder
Patient was taking Kenalog (View Usage). After Kenalog was administered, patient had the following side effects: atrophy, eyelid disorder on Jun 25, 2009 from UNITED STATES Additional patient health information: Female patient , 40 years of age, weighting 115.0 lb, was diagnosed with chalazion and. Kenalog dosage: Once Intralesional.

6247205-5 | Injection Site Atrophy, Injection Site Discolouration
Adverse event was reported on Jun 24, 2009 by a Female patient taking Kenalog (View Usage) (Dosage: Shot Once) was diagnosed with sinus congestion and. Location: UNITED STATES , weighting 145.0 lb, Patient experienced the following unwanted or unexpected effects: injection site atrophy, injection site discolouration.

6232786-8 | Injection Site Reaction, Menstruation Irregular, Muscle Disorder, Night Sweats, Paraesthesia, Skin Atrophy, Sleep Disorder, Soft Tissue Disorder, Weight Increased
on Jun 12, 2009 Female patient from UNITED STATES , weighting 141.0 lb, was diagnosed with exposure to toxic agent and was treated with Kenalog (View Usage). Patient had the following side effects: injection site reaction, menstruation irregular, muscle disorder (What is muscle disorder?), night sweats, paraesthesia, skin atrophy, sleep disorder (What is sleep disorder?), soft tissue disorder, weight increased. Kenalog dosage: .

6228892-4 | Diabetes Mellitus
on Jun 08, 2009 Female patient from GERMANY , 78 years of age, was diagnosed with arthritis (What is arthritis?), gastric ulcer, dysuria, neuropathy peripheral and was treated with Kenalog (View Usage). After Kenalog was administered, patient had the following side effects: diabetes mellitus. Kenalog dosage: . During the same period patient was treated with CALCIUM + VITAMIN D (View Calcium + Vitamin D Review and Calcium + Vitamin D Label ), L LYSINE (View L-lysine Review and L-lysine Label ), VITAMIN B COMPLEX + C (View Vitamin B Complex + C Review and Vitamin B Complex + C Label ), MYLANTA (View Mylanta Review and Mylanta Label ), PHENAZOPYRIDINE HCL TAB (View Phenazopyridine Hcl Tab Review and Phenazopyridine Hcl Tab Label ), PROPOXYPHENE HCL CAP (View Propoxyphene Hcl Cap Review and Propoxyphene Hcl Cap Label ), LYRICA (View Lyrica Review and Lyrica Label ), SUCRALFATE (View Sucralfate Review and Sucralfate Label ). Patient was hospitalized.

6219229-5 | Blood Blister, Blood Disorder, Capillary Disorder, Contusion, Erythema, Injection Site Haemorrhage, Injection Site Reaction, Skin Atrophy, Skin Fragility
Patient was taking Kenalog (View Usage). Patient experienced the following unwanted or unexpected effects: blood blister, blood disorder, capillary disorder, contusion, erythema, injection site haemorrhage, injection site reaction, skin atrophy, skin fragility on Jun 05, 2009 from UNITED STATES Additional patient health information: Female patient , weighting 135.0 lb, was diagnosed with tendonitis and. Kenalog dosage: One Injection.

6216649-X | Elbow Deformity, Hypersensitivity, Injection Site Reaction, Pruritus, Skin Atrophy
Adverse event was reported on Jun 03, 2009 by a Female patient taking Kenalog (View Usage) (Dosage: Single Injection) was diagnosed with epicondylitis and. Location: UNITED STATES , weighting 125.0 lb, Patient had the following side effects: elbow deformity, hypersensitivity, injection site reaction, pruritus, skin atrophy.

6210360-7 | Injection Site Discolouration, Injection Site Reaction, Pain
on May 29, 2009 Female patient from UNITED STATES , 26 years of age, weighting 165.0 lb, was diagnosed with sinusitis (What is sinusitis?) and was treated with Kenalog (View Usage). After Kenalog was administered, patient had the following side effects: injection site discolouration, injection site reaction, pain (What is pain?). Kenalog dosage: 80 Mg Once One Use.

6192130-1 | Blood Pressure Decreased, Myocardial Infarction
on May 13, 2009 Female patient from UNITED STATES , 64 years of age, was diagnosed with back pain (What is back pain?) and was treated with Kenalog (View Usage). Patient experienced the following unwanted or unexpected effects: blood pressure decreased, myocardial infarction. Kenalog dosage: . During the same period patient was treated with LIDOCAINE (1 Dosage Form = 170(unit Not Specified)) (View Lidocaine Review and Lidocaine Label ), MARCAINE (1 Dosage Form = 0.25(unit Not Specified)) (View Marcaine Review and Marcaine Label ), OMNIPAQUE 140 (1 Dosage Form = 180(unit Not Specified)) (View Omnipaque 140 Review and Omnipaque 140 Label ), TIMOLOL MALEATE (1 Dosage Form=0.5(unit Not Specified); Last Dose On 28apr09) (View Timolol Maleate Review and Timolol Maleate Label ), XALATAN (1 Dosage Form=005(unit Not Specified); Last Dose On 23apr09) (View Xalatan Review and Xalatan Label ), AMITRIPTLINE HYDROCHLORIDE TAB (Last Dose On 23apr09) (View Amitriptline Hydrochloride Tab Review and Amitriptline Hydrochloride Tab Label ), GLIMEPIRIDE (1df=4mg [1/2 2 Times/day];last Dose On 24apr09) (View Glimepiride Review and Glimepiride Label ), ACTOPLUS MET (1 Dosage Form=15/850;last Dose On 24apr09) (View Actoplus Met Review and Actoplus Met Label ). Patient was hospitalized.

6190791-4 | Blood Pressure Increased, Electrocardiogram T Wave Inversion, Haemorrhage, Headache, Respiratory Disorder, Thrombosis
Patient was taking Kenalog (View Usage). Patient had the following side effects: blood pressure increased, electrocardiogram t wave inversion, haemorrhage, headache (What is headache?), respiratory disorder, thrombosis on May 13, 2009 from UNITED STATES Additional patient health information: Female patient , 37 years of age, weighting 142.0 lb, was diagnosed with allergy to plants and. Kenalog dosage: . During the same period patient was treated with ADVAIR HFA (View Advair Hfa Review and Advair Hfa Label ).

6186730-2 | Aggression, Anxiety, Emotional Disorder
Adverse event was reported on May 08, 2009 by a Female patient taking Kenalog (View Usage) (Dosage: 1 Cc Acute For Asth,a Cutaneous) was diagnosed with asthma (What is asthma?) and. Location: UNITED STATES , 40 years of age, weighting 111.0 lb, After Kenalog was administered, patient had the following side effects: aggression, anxiety (What is anxiety?), emotional disorder.

6184106-5 | Myalgia, Skin Disorder
on May 06, 2009 Female patient from UNITED STATES , 51 years of age, weighting 131.0 lb, was diagnosed with rhinitis and was treated with Kenalog (View Usage). Patient experienced the following unwanted or unexpected effects: myalgia, skin disorder. Kenalog dosage: 40 Mg 1 Im I Dose.

6171232-X | Abdominal Distension, Aphonia, Asthenia, Asthma, Blood Pressure Increased, Candidiasis, Chronic Obstructive Pulmonary Disease, Dyspnoea, Fatigue
on Apr 28, 2009 Female patient from UNITED STATES , 65 years of age, weighting 192.0 lb, was diagnosed with intervertebral disc protrusion and was treated with Kenalog (View Usage). Patient had the following side effects: abdominal distension, aphonia, asthenia, asthma (What is asthma?), blood pressure increased, candidiasis, chronic obstructive pulmonary disease, dyspnoea, fatigue. Kenalog dosage: 47 Mg 7-21 Days Epidural. During the same period patient was treated with METHYLPREDNISOLONE (21 4mg Dose 6,5,4,3,2,1 Daily Po) (View Methylprednisolone Review and Methylprednisolone Label ).

6160334-X | Skin Discolouration, Skin Disorder
Patient was taking Kenalog (View Usage). After Kenalog was administered, patient had the following side effects: skin discolouration, skin disorder on Apr 15, 2009 from UNITED STATES Additional patient health information: Female patient , child 11 years of age, weighting 90.00 lb, was diagnosed with rash (What is rash?), rash papular and. Kenalog dosage: .

6150623-7 | Injection Site Discolouration, Injection Site Reaction
Adverse event was reported on Apr 08, 2009 by a Female patient taking Kenalog (View Usage) (Dosage: 1 Shot) was diagnosed with bronchitis (What is bronchitis?), ear infection (What is ear infection?), sinusitis (What is sinusitis?) and. Location: UNITED STATES , 51 years of age, weighting 130.0 lb, Patient experienced the following unwanted or unexpected effects: injection site discolouration, injection site reaction.

6149686-4 | Injection Site Discolouration, Injection Site Discomfort, Injection Site Reaction
on Apr 07, 2009 Male patient from UNITED STATES , 28 years of age, weighting 160.0 lb, was diagnosed with skin irritation and was treated with Kenalog (View Usage). Patient had the following side effects: injection site discolouration, injection site discomfort, injection site reaction. Kenalog dosage: One Shot.

6124544-X | Agitation, Arrhythmia, Contusion, Disturbance In Attention, Energy Increased, Euphoric Mood, Hunger, Ill-defined Disorder, Insomnia
on Mar 17, 2009 Female patient from UNITED STATES , 70 years of age, weighting 119.0 lb, was diagnosed with arthritis (What is arthritis?) and was treated with Kenalog (View Usage). After Kenalog was administered, patient had the following side effects: agitation, arrhythmia (What is arrhythmia?), contusion, disturbance in attention, energy increased, euphoric mood, hunger, ill-defined disorder, insomnia. Kenalog dosage: Unk 1 Periarticular One Time. During the same period patient was treated with BUVIVIDICAINE UNK UNK (0.251 1 Periarticular One Time) (View Buvividicaine Unk Unk Review and Buvividicaine Unk Unk Label ).

6124387-7 | Injection Site Reaction, Product Quality Issue
Patient was taking Kenalog (View Usage). Patient experienced the following unwanted or unexpected effects: injection site reaction, product quality issue on Mar 18, 2009 from UNITED STATES Additional patient health information: Female patient , 63 years of age, weighting 130.0 lb, was diagnosed with multiple allergies and. Kenalog dosage: .

6112380-X | Injection Site Reaction
Adverse event was reported on Mar 11, 2009 by a Female patient taking Kenalog (View Usage) (Dosage: ) was diagnosed with multiple allergies and. Location: UNITED STATES , 26 years of age, weighting 136.0 lb, Patient had the following side effects: injection site reaction.

6101833-6 | Atrophy, Deformity, Injection Site Reaction, Skin Discolouration, Skin Disorder, Skin Induration
on Mar 03, 2009 Female patient from UNITED STATES , weighting 137.0 lb, was diagnosed with bursitis (What is bursitis?) and was treated with Kenalog (View Usage). After Kenalog was administered, patient had the following side effects: atrophy, deformity, injection site reaction, skin discolouration, skin disorder, skin induration. Kenalog dosage: Left And Right Shoulder Once Im.

6093743-8 | Arthralgia, Asthenia, Injection Site Reaction, Pain In Extremity
on Feb 23, 2009 Female patient from UNITED STATES , weighting 125.0 lb, was diagnosed with multiple allergies and was treated with Kenalog (View Usage). Patient experienced the following unwanted or unexpected effects: arthralgia, asthenia, injection site reaction, pain in extremity. Kenalog dosage: .

6093679-2 | Injection Site Induration, Injection Site Reaction, Injection Site Scar
Patient was taking Kenalog (View Usage). Patient had the following side effects: injection site induration, injection site reaction, injection site scar on Feb 20, 2009 from UNITED STATES Additional patient health information: Female patient , weighting 135.0 lb, . Kenalog dosage: . Patient was hospitalized.

6093091-6 | Injection Site Reaction
Adverse event was reported on Feb 24, 2009 by a Female patient taking Kenalog (View Usage) (Dosage: ) was diagnosed with dry skin and. Location: UNITED STATES , weighting 125.0 lb, After Kenalog was administered, patient had the following side effects: injection site reaction.

6092673-5 | Injection Site Reaction, Skin Disorder
on Feb 23, 2009 Female patient from UNITED STATES , weighting 22.00 lb, was diagnosed with arthropod bite and was treated with Kenalog (View Usage). Patient experienced the following unwanted or unexpected effects: injection site reaction, skin disorder. Kenalog dosage: .

6092607-3 | Acrochordon, Agitation, Disturbance In Attention, Insomnia, Muscular Weakness, Skin Papilloma, Tinnitus, Visual Acuity Reduced
on Dec 04, 2008 Male patient from UNITED STATES , 68 years of age, weighting 185.2 lb, was diagnosed with rash (What is rash?) and was treated with Kenalog (View Usage). Patient had the following side effects: acrochordon, agitation, disturbance in attention, insomnia, muscular weakness, skin papilloma, tinnitus (What is tinnitus?), visual acuity reduced. Kenalog dosage: .

6092606-1 | Injection Site Atrophy
Patient was taking Kenalog (View Usage). After Kenalog was administered, patient had the following side effects: injection site atrophy on Nov 18, 2008 from UNITED STATES Additional patient health information: Female patient , 17 years of age, weighting 114.6 lb, was diagnosed with respiratory tract infection and. Kenalog dosage: .

6092600-0 | Blood Glucose Increased, Headache
Adverse event was reported on Oct 02, 2008 by a Female patient taking Kenalog (View Usage) (Dosage: Kenalog 10. 2nd Inj On 26sep08) . Location: UNITED STATES , 52 years of age, weighting 180.8 lb, Patient experienced the following unwanted or unexpected effects: blood glucose increased, headache (What is headache?). During the same period patient was treated with LEVOTHYROXINE SODIUM (View Levothyroxine Sodium Review and Levothyroxine Sodium Label ), NOVOLOG (Novolog Insulin Pump) (View Novolog Review and Novolog Label ), METFORMIN HCL (View Metformin Hcl Review and Metformin Hcl Label ), DIOVAN HCT (Diovan Hct 320 25mg) (View Diovan Hct Review and Diovan Hct Label ), LIPITOR (View Lipitor Review and Lipitor Label ), ACETAZOLAMIDE (View Acetazolamide Review and Acetazolamide Label ).

6092598-5 | Injection Site Atrophy, Injection Site Discolouration, Injection Site Pain
on Jul 14, 2008 Female patient from UNITED STATES , 43 years of age, weighting 130.1 lb, was diagnosed with bursitis (What is bursitis?) and was treated with Kenalog (View Usage). Patient had the following side effects: injection site atrophy, injection site discolouration, injection site pain. Kenalog dosage: .

6092596-1 | Menstrual Disorder
on Jun 19, 2008 Female patient from UNITED STATES , 47 years of age, weighting 145.5 lb, was diagnosed with hypersensitivity and was treated with Kenalog (View Usage). After Kenalog was administered, patient had the following side effects: menstrual disorder. Kenalog dosage: .

6092595-X | Anxiety, Diarrhoea, Insomnia, Nausea, Nervousness
Patient was taking Kenalog (View Usage). Patient experienced the following unwanted or unexpected effects: anxiety (What is anxiety?), diarrhoea, insomnia, nausea (What is nausea?), nervousness on Jun 18, 2008 from UNITED STATES Additional patient health information: Female patient , 50 years of age, weighting 165.3 lb, was diagnosed with sciatica (What is sciatica?) and. Kenalog dosage: . During the same period patient was treated with TOPROL XL (View Toprol-xl Review and Toprol-xl Label ), BENTYL (View Bentyl Review and Bentyl Label ), CRESTOR (View Crestor Review and Crestor Label ), AGRYLIN (View Agrylin Review and Agrylin Label ), XANAX (View Xanax Review and Xanax Label ).

6092593-6 | Muscle Atrophy
Adverse event was reported on May 27, 2008 by a Female patient taking Kenalog (View Usage) (Dosage: ) . Location: UNITED STATES , 27 years of age, weighting 134.5 lb, Patient had the following side effects: muscle atrophy. During the same period patient was treated with TRINESSA (View Trinessa Review and Trinessa Label ), ADDERALL 10 (View Adderall 10 Review and Adderall 10 Label ).

6092592-4 | Injection Site Atrophy, Injection Site Pain
on May 21, 2008 Female patient from UNITED STATES , 26 years of age, weighting 105.8 lb, was diagnosed with back pain (What is back pain?) and was treated with Kenalog (View Usage). After Kenalog was administered, patient had the following side effects: injection site atrophy, injection site pain. Kenalog dosage: Received Injection On Jan 2008 Or Feb 2008.

6092591-2 | Dry Mouth, Injection Site Discolouration, Injection Site Reaction, Menstruation Irregular, Pollakiuria
on May 15, 2008 Female patient from UNITED STATES , 34 years of age, weighting 97.00 lb, was treated with Kenalog (View Usage). Patient experienced the following unwanted or unexpected effects: dry mouth, injection site discolouration, injection site reaction, menstruation irregular, pollakiuria. Kenalog dosage: Dosage Form = Injection.

6092584-5 | Lipoatrophy
Patient was taking Kenalog (View Usage). Patient had the following side effects: lipoatrophy on Mar 05, 2008 from UNITED STATES Additional patient health information: Female patient , 29 years of age, . Kenalog dosage: .

6092583-3 | Blood Cortisol Decreased, Menstruation Irregular
Adverse event was reported on Mar 03, 2008 by a Female patient taking Kenalog (View Usage) (Dosage: ) was diagnosed with bronchitis (What is bronchitis?) and. Location: UNITED STATES , 44 years of age, weighting 99.21 lb, After Kenalog was administered, patient had the following side effects: blood cortisol decreased, menstruation irregular.

6092582-1 | Skin Atrophy, Skin Discolouration
on Oct 06, 2008 Female patient from UNITED STATES , 45 years of age, weighting 154.3 lb, was diagnosed with house dust allergy, mycotic allergy, seasonal allergy, allergy to animal and was treated with Kenalog (View Usage). Patient experienced the following unwanted or unexpected effects: skin atrophy, skin discolouration. Kenalog dosage: . During the same period patient was treated with SYNTHROID (View Synthroid Review and Synthroid Label ), ESTROGENIC SUBSTANCE (View Estrogenic Substance Review and Estrogenic Substance Label ).

6092577-8 | Flushing, Heart Rate Increased, Muscle Spasms
on Mar 06, 2008 Male patient from UNITED STATES , 41 years of age, weighting 229.3 lb, was diagnosed with musculoskeletal pain, injury and was treated with Kenalog (View Usage). Patient had the following side effects: flushing, heart rate increased, muscle spasms. Kenalog dosage: . During the same period patient was treated with MARCAINE (Marcaine 0.5%) (View Marcaine Review and Marcaine Label ), DIOVAN (View Diovan Review and Diovan Label ), CLONAZEPAM (View Clonazepam Review and Clonazepam Label ).

6092575-4 | Injection Site Pain, Muscle Atrophy
Patient was taking Kenalog (View Usage). After Kenalog was administered, patient had the following side effects: injection site pain, muscle atrophy on May 29, 2008 from UNITED STATES Additional patient health information: Female patient , 48 years of age, was diagnosed with hypersensitivity and. Kenalog dosage: .

6085707-5 | Agitation, Crying, Deformity, Skin Discolouration, Sleep Disorder
Adverse event was reported on Feb 17, 2009 by a Male patient taking Kenalog (View Usage) (Dosage: 2cc Once Id) was diagnosed with post procedural swelling and. Location: UNITED STATES , weighting 26.00 lb, Patient experienced the following unwanted or unexpected effects: agitation, crying, deformity, skin discolouration, sleep disorder (What is sleep disorder?).

6057504-8 | Injection Site Discolouration, Injection Site Reaction, Menstrual Disorder, Metrorrhagia, Oligomenorrhoea
on Jan 27, 2009 Female patient from UNITED STATES , 45 years of age, weighting 104.0 lb, was diagnosed with psoriasis and was treated with Kenalog (View Usage). Patient had the following side effects: injection site discolouration, injection site reaction, menstrual disorder, metrorrhagia, oligomenorrhoea. Kenalog dosage: Injection 1x.

6057388-8 | Injection Site Pain, Injection Site Reaction
on Jan 26, 2009 Female patient from UNITED STATES , weighting 138.0 lb, was diagnosed with hypersensitivity, seasonal allergy and was treated with Kenalog (View Usage). After Kenalog was administered, patient had the following side effects: injection site pain, injection site reaction. Kenalog dosage: Im.

6051335-0 | Back Pain, Hip Deformity, Injection Site Pain, Injection Site Reaction, Skin Disorder
Patient was taking Kenalog (View Usage). Patient experienced the following unwanted or unexpected effects: back pain (What is back pain?), hip deformity, injection site pain, injection site reaction, skin disorder on Jan 21, 2009 from UNITED STATES Additional patient health information: Female patient , 34 years of age, weighting 125.0 lb, was diagnosed with sinusitis (What is sinusitis?) and. Kenalog dosage: .

6046208-3 | Injection Site Reaction, Musculoskeletal Pain, Skin Disorder
Adverse event was reported on Jan 21, 2009 by a Female patient taking Kenalog (View Usage) (Dosage: ) . Location: UNITED STATES , 34 years of age, weighting 118.0 lb, Patient had the following side effects: injection site reaction, musculoskeletal pain, skin disorder.

6039016-0 |
on Jan 13, 2009 Female patient from UNITED STATES , 42 years of age, weighting 238.1 lb, was treated with Kenalog (View Usage). . Kenalog dosage: . During the same period patient was treated with TYLENOL (CAPLET) (View Tylenol (caplet) Review and Tylenol (caplet) Label ), MOTRIN (View Motrin Review and Motrin Label ), MULTI VITAMIN (View Multi-vitamin Review and Multi-vitamin Label ), TOPAMAX (View Topamax Review and Topamax Label ).

6038962-1 | Injection Site Reaction
on Jan 14, 2009 Female patient from UNITED STATES , weighting 112.0 lb, was treated with Kenalog (View Usage). Patient experienced the following unwanted or unexpected effects: injection site reaction. Kenalog dosage: Twice.

6037853-X | Injection Site Discolouration, Skin Reaction
Patient was taking Kenalog (View Usage). Patient had the following side effects: injection site discolouration, skin reaction on Jan 14, 2009 from UNITED STATES Additional patient health information: Female patient , 37 years of age, weighting 162.0 lb, was diagnosed with influenza, nasopharyngitis and. Kenalog dosage: 80mg Once Sq.